Sputnik

The Russian Covid-19 vaccine ‘Sputnik V’ developer on December 14 reported that the vaccine has indicated more than 91.4% efficacy in the clinical trials. Reportedly, under the registered clinical trials of Sputnik V, more than 26,000 volunteers were vaccinated in Russia. In an official statement, the developers said that "No unexpected adverse events were identified as a part of the research." Moreover, In India, Sputnik V trials are being… read-more